/ Modified apr 17, 2021 8:05 a.m.

Spread of COVID variant concerning to ASU expert

A discussion with Dr. Joshua LaBaer, executive director of the ASU Biodesign Institute.

Like the rest of the country, distribution of the Johnson and Johnson COVID-19 vaccine is on pause as the CDC and FDA look into reports that a handful of recipients developed blood clots. That revelation kicked off our discussion with Joshua LaBaer, executive director of Arizona State University’s Biodesign Institute. LaBaer also discussed the institute’s recent discovery of a variant of the disease that developed in the state and the ongoing spread of the variant that emerged from the United Kingdom.

Arizona 360
Arizona 360 airs Fridays at 8:30 p.m. on PBS 6 and Saturdays at 8 p.m. on PBS 6 PLUS. See more from Arizona 360.
By posting comments, you agree to our
AZPM encourages comments, but comments that contain profanity, unrelated information, threats, libel, defamatory statements, obscenities, pornography or that violate the law are not allowed. Comments that promote commercial products or services are not allowed. Comments in violation of this policy will be removed. Continued posting of comments that violate this policy will result in the commenter being banned from the site.

By submitting your comments, you hereby give AZPM the right to post your comments and potentially use them in any other form of media operated by this institution.
Arizona Public Media broadcast stations are licensed to the Arizona Board of Regents. Arizona Public Media and AZPM are registered trademarks of the Arizona Board of Regents.
The University of Arizona